Cargando…

Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin significantly improves live birth rate for women with diminished ovarian reserve

BACKGROUND: Diminished ovarian reserve (DOR) remains one of the greatest obstacles affecting the chance of a successful live birth after fertility treatment. The present study was set to investigate whether using a “dual trigger” consisted of human chorionic gonadotropin (hCG) plus gonadotropin rele...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Ming-Huei, Wu, Frank Shao-Ying, Hwu, Yuh-Ming, Lee, Robert Kuo-Kuang, Li, Ryh-Sheng, Li, Sheng-Hsiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320621/ https://www.ncbi.nlm.nih.gov/pubmed/30609935 http://dx.doi.org/10.1186/s12958-018-0451-x

Ejemplares similares

Final Oocyte Maturation in Assisted Reproduction with Human Chorionic Gonadotropin and Gonadotropin-releasing Hormone agonist (Dual Trigger)
por: de Oliveira, Sofia Andrade, et al.
Publicado: (2016)

Dual trigger with gonadotropin-releasing hormone agonist and recombinant human chorionic gonadotropin improves the outcome of intrauterine insemination
por: Halim, Binarwan, et al.
Publicado: (2022)

Dual trigger with gonadotropin-releasing hormone and human chorionic gonadotropin for poor responders
por: Eser, Ahmet, et al.
Publicado: (2018)

Clinical efficacy of dual trigger with human chorionic gonadotropin and a gonadotropin‐releasing hormone agonist for women undergoing fertility preservation
por: Hong, Yeon Hee, et al.
Publicado: (2022)

The live birth rate of vitrified oocyte accumulation for managing diminished ovarian reserve: a retrospective cohort study
por: Lee, Kuan-Sheng, et al.
Publicado: (2023)

Dual Trigger with Gonadotropin Releasing Hormone Agonist and Human Chorionic Gonadotropin of Fresh Autologous Cycles in High Responders: A Systematic Review
por: Vyrides, Andreas A, et al.
Publicado: (2022)

Effects of gonadotropin-releasing hormone agonist on human chorionic gonadotropin activity in granulosa cells of immature female rats
por: TUNGMAHASUK, Doungrut, et al.
Publicado: (2017)

Gonadotropin-releasing hormone agonist triggering with concomitant administration of low doses of human chorionic gonadotropin or a freeze-all strategy in high responders
por: Karacan, Meric, et al.
Publicado: (2017)

Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study
por: Mahajan, Nalini, et al.
Publicado: (2016)

Dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves oocyte yield in normal responders on GnRH-antagonist cycles
por: Albeitawi, Soha, et al.
Publicado: (2022)

Human Chorionic Gonadotropin: The Pregnancy Hormone and More
por: Theofanakis, Charalampos, et al.
Publicado: (2017)

A borderline form of empty follicle syndrome treated with a double-trigger of gonadotropin-releasing hormone agonist and human chorionic gonadotropin: A case report
por: Song, Jingyan, et al.
Publicado: (2019)

Comparing the effect of gonadotropin-releasing hormone agonist and human chorionic gonadotropin on final oocytes for ovulation triggering among infertile women undergoing intrauterine insemination: An RCT
por: Taheripanah, Robabeh, et al.
Publicado: (2017)

Luteal Coasting and Individualization of Human Chorionic Gonadotropin Dose after Gonadotropin-Releasing Hormone Agonist Triggering for Final Oocyte Maturation—A Retrospective Proof-of-Concept Study
por: Lawrenz, Barbara, et al.
Publicado: (2018)

Experimental Production of Gynecomastia with Chorionic Gonadotropin
por: Klatskin, Gerald, et al.
Publicado: (1952)

Chorionic gonadotropin and uterine dialogue in the primate
por: Cameo, Paula, et al.
Publicado: (2004)

IMMUNOHISTOCHEMICAL LOCALIZATION OF HUMAN CHORIONIC GONADOTROPIN
por: Midgley, A. R., et al.
Publicado: (1962)

Human Chorionic Gonadotropin and Breast Cancer
por: Schüler-Toprak, Susanne, et al.
Publicado: (2017)

Live births from in vitro fertilization-embryo transfer following the administration of gonadotropin-releasing hormone agonist without gonadotropins: Two case reports
por: Li, Mai, et al.
Publicado: (2023)

Quantitative analysis of total β-subunit of human chorionic gonadotropin concentration in urine by immunomagnetic reduction to assist in the diagnosis of ectopic pregnancy
por: Chen, Chen-Yu, et al.
Publicado: (2015)

Gonadotropin-releasing hormone agonist trigger is a better alternative than human chorionic gonadotropin in PCOS undergoing IVF cycles for an OHSS Free Clinic: A Randomized control trial
por: Krishna, Deepika, et al.
Publicado: (2016)

Fertility Rates of Ewes Treated with Medroxyprogesterone and Injected with Equine Chorionic Gonadotropin plus Human Chorionic Gonadotropin in Anoestrous Season
por: Santos, I. W., et al.
Publicado: (2010)

The relationship between the variants in the 5′-untranslated regions of equine chorionic gonadotropin genes and serum equine chorionic gonadotropin levels
por: Liu, ShuQin, et al.
Publicado: (2017)

Prevention of Premature Ovulation by Administration of Gonadotropin Releasing Hormone Antagonist the day After Ovulation Triggering in Diminished Ovarian Reserve Patients
por: Sik, Bulat Aytek, et al.
Publicado: (2022)

Efficacy and safety of human chorionic gonadotropin combined with human menopausal gonadotropin and a gonadotropin-releasing hormone pump for male adolescents with congenital hypogonadotropic hypogonadism
por: Liu, Ying, et al.
Publicado: (2021)

Single‐dose pharmacokinetic study comparing the pharmacokinetics of recombinant human chorionic gonadotropin in healthy Japanese and Caucasian women and recombinant human chorionic gonadotropin and urinary human chorionic gonadotropin in healthy Japanese women
por: Bagchus, Wilhelmina, et al.
Publicado: (2017)

Human Chorionic Gonadotropin and Early Embryogenesis: Review
por: d’Hauterive, Sophie Perrier, et al.
Publicado: (2022)

Reproductive responses of dairy cows with ovarian cysts to simultaneous human chorionic gonadotropin or gonadotropin-releasing hormone and cloprostenol compared to gonadotropin-releasing hormone alone treatment
por: Taktaz, T., et al.
Publicado: (2015)

Production of Mare Chorionic Girdle Organoids That Secrete Equine Chorionic Gonadotropin
por: Thompson, Riley E., et al.
Publicado: (2023)

Is Human Chorionic Gonadotropin Trigger Beneficial for Natural Cycle Frozen-Thawed Embryo Transfer?
por: Gao, Dan-Dan, et al.
Publicado: (2021)

Ovarian Follicular Growth through Intermittent Vaginal Gonadotropin Administration in Diminished Ovarian Reserve Women
por: Hsu, Chao-Chin, et al.
Publicado: (2022)

Gonadotropin-releasing hormone agonist ovulation trigger—beyond OHSS prevention
por: Castillo, Juan Carlos, et al.
Publicado: (2020)

Luteinizing hormone and human chorionic gonadotropin: distinguishing unique physiologic roles
por: Choi, Janet, et al.
Publicado: (2014)

Effects of reduced follicle-stimulating hormone dosage before human chorionic gonadotropin trigger on in vitro fertilization outcomes
por: Ou, Zhanhui, et al.
Publicado: (2023)

New discoveries on the biology and detection of human chorionic gonadotropin
por: Cole, Laurence A
Publicado: (2009)

Management of Nonpregnant Women with Elevated Human Chorionic Gonadotropin
por: Schmid, Bernd C., et al.
Publicado: (2013)

Endometrial carcinoma with ectopic human chorionic gonadotropin expression
por: Lee, Regina, et al.
Publicado: (2015)

Human Chorionic Gonadotropin Influences Systemic Autoimmune Responses
por: De, Alpana, et al.
Publicado: (2018)

Chorionic gonadotropin: Ovarian hyperstimulation syndrome: case report
Publicado: (2021)

Impact of mode of conception on early pregnancy human chorionic gonadotropin rise and birth weight
por: Richardson, Hayley, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2a3s2mrndqkac6k20ctoa9tkr0